piperaquine tetraphosphate

URI: https://gptkb.org/entity/piperaquine_tetraphosphate
GPTKB entity
Statements (34)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkbp:administered_with gptkb:artemisinin
gptkb:dihydroartemisinin
gptkbp:ATCCode gptkb:P01BF05
gptkbp:CASNumber 4085-31-8
gptkbp:chemicalClass gptkb:4-aminoquinoline
gptkbp:component artemisinin-based combination therapy
gptkbp:contraindication known hypersensitivity
severe cardiac disease
gptkbp:developedBy gptkb:China
gptkbp:discoveredBy 1960s
gptkbp:eliminationHalfLife 17-33 days
gptkbp:excretion urine
feces
gptkbp:hasInChIKey QJQYJZLPKQJHQQ-UHFFFAOYSA-N
gptkbp:hasMolecularFormula C38H52Cl2N4O8P2
gptkbp:hasSMILES C1CN(CCC1)CCC(C2=CC(=NC3=C2C=CC=C3Cl)Cl)CCCN4CCC(CC4)CCC5=CC(=NC6=C5C=CC=C6Cl)Cl
gptkbp:hasUNII 8QX8J8Y6ZB
https://www.w3.org/2000/01/rdf-schema#label piperaquine tetraphosphate
gptkbp:IUPACName 1,3-bis(1,7-dichloroquinolin-4-yl)-1,3-dipiperidin-4-ylpropane tetraphosphate
gptkbp:legalStatus prescription only
gptkbp:meltingPoint >300°C
gptkbp:metabolism liver
gptkbp:PubChem_CID 21106313
54680682
gptkbp:routeOfAdministration oral
gptkbp:sideEffect headache
QT prolongation
gastrointestinal disturbance
gptkbp:usedFor gptkb:Plasmodium_falciparum_malaria
antiviral drug
Plasmodium vivax malaria
gptkbp:bfsParent gptkb:piperaquine
gptkbp:bfsLayer 7